Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate ...

EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...

Prostate cancer screening should be promised in the next Tory manifesto, a former home secretary has said. Sir James Cleverly ...

AWARENESS MONTH, AND ACCORDING TO THE AMERICAN CANCER SOCIETY, THE DISEASE SEES OVER 300,000 NEW CASES YEARLY, AS WELL AS MORE THAN 35,000 DEATHS A YEAR, MAKING IT CRUCIAL FOR MEN TO UNDERGO A ...

Profiling BCRAness phenotype in public prostate cancer datasets without homologous repair gene mutations. Cardiometabolic health’s influence on outcomes in men with localized high-risk prostate cancer ...

Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced today that it was granted CE ...

Simeon Greene, from Wolverhampton, believes 54 of his relatives may have had prostate cancer.